127 related articles for article (PubMed ID: 30005182)
1. Factors associated with a prolonged hospital stay during induction chemotherapy in newly diagnosed high risk pediatric acute lymphoblastic leukemia.
Warrick K; Althouse SK; Rahrig A; Rupenthal J; Batra S
Leuk Res; 2018 Aug; 71():36-42. PubMed ID: 30005182
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Hospital Length of Stay on Readmissions for Children With Newly Diagnosed Acute Lymphoblastic Leukemia.
Wedekind MF; Dennis R; Sturm M; Koch T; Stanek J; O'Brien SH
J Pediatr Hematol Oncol; 2016 Jul; 38(5):329-33. PubMed ID: 26989914
[TBL] [Abstract][Full Text] [Related]
3. Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals.
Goodman EK; Reilly AF; Fisher BT; Fitzgerald J; Li Y; Seif AE; Huang YS; Bagatell R; Aplenc R
JAMA Pediatr; 2014 Oct; 168(10):925-31. PubMed ID: 25155012
[TBL] [Abstract][Full Text] [Related]
4. Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
Farkas T; Müller J; Erdelyi DJ; Csoka M; Kovacs GT
Pathol Oncol Res; 2017 Oct; 23(4):889-897. PubMed ID: 28138921
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
6. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
7. Coagulation profile during induction chemotherapy in childhood acute lymphoblastic leukemia.
Sehgal S; Sharma S; Chandra J; Nangia A
Indian J Pathol Microbiol; 2017; 60(1):50-56. PubMed ID: 28195091
[TBL] [Abstract][Full Text] [Related]
8. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia requiring insulin during acute lymphoblastic leukemia induction chemotherapy is associated with increased adverse outcomes and healthcare costs.
McCormick MC; Sharp E; Kalpatthi R; Zullo J; Gurtunca N; Zhang J; Krafty R; Raman S
Pediatr Blood Cancer; 2020 Sep; 67(9):e28475. PubMed ID: 32589365
[TBL] [Abstract][Full Text] [Related]
10. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
[TBL] [Abstract][Full Text] [Related]
11. Substitution with doxorubicin for daunorubicin during induction for high risk pediatric acute lymphoblastic leukemia results in increased toxicity.
Gardner RA; Thomson B; Hawkins DS
Pediatr Blood Cancer; 2013 Feb; 60(2):338-9. PubMed ID: 23015453
[No Abstract] [Full Text] [Related]
12. Vincristine toxicity with co-administration of fluconazole during induction therapy for pediatric acute lymphoblastic leukemia.
Smitherman AB; Faircloth CB; Deal A; Troy M; Gold SH
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28333402
[TBL] [Abstract][Full Text] [Related]
13. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of pediatric acute lymphoblastic leukemia in Yeungnam region: Multicenter retrospective study of Study Alliance of Yeungnam Pediatric Hematology-Oncology (SAYPH).
Yang EJ; Park KM; Lee JM; Hah JO; Park SK; Suh JK; Kim JY; Lee KS; Park J; Park ES; Lim J; Shim YJ; Kim HS; Kong SG; Chueh H; Choi EJ; Park JA; Lim YT
Pediatr Hematol Oncol; 2018 May; 35(4):276-287. PubMed ID: 30633619
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of mitoxantrone as frontline anthracycline during induction therapy in adults with newly diagnosed acute lymphoblastic leukemia: a single-center experience.
Jaime-Perez JC; Colunga-Pedraza PR; Gutiérrez-Aguirre CH; Pinzón-Uresti MA; Cantú-Rodríguez OG; Herrera-Garza JL; Gómez-Almaguer D
Leuk Lymphoma; 2015; 56(9):2524-8. PubMed ID: 25629985
[TBL] [Abstract][Full Text] [Related]
16. Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma.
Ishihara Y; Kimura S; Akahoshi Y; Harada N; Nakano H; Kameda K; Ugai T; Wada H; Yamasaki R; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Usuki K; Kanda Y
Hematology; 2016 Jan; 21(1):19-25. PubMed ID: 26352559
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from CYP-C.
Pelland-Marcotte MC; Kulkarni K; Tran TH; Stammers D; Gupta S; Sung L; Athale UH
Am J Hematol; 2024 Feb; 99(2):274-283. PubMed ID: 38164978
[TBL] [Abstract][Full Text] [Related]
18. Mucormycosis diagnosed during induction chemotherapy in five pediatric patients with acute lymphoblastic leukemia.
Aftandilian C; Eguiguren L; Mathew R; Messner A
Pediatr Blood Cancer; 2019 Sep; 66(9):e27834. PubMed ID: 31131954
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in obese patients undergoing induction therapy for acute leukemia.
Dombrowski L; Mohassel L
J Oncol Pharm Pract; 2019 Jul; 25(5):1058-1065. PubMed ID: 29726788
[TBL] [Abstract][Full Text] [Related]
20. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
Sun D; Elson P; Liedtke M; Medeiros BC; Earl M; Alizadeh A; Bates J; Sekeres MA; Coutre S; Kalaycio M; Sobecks R; Copelan E; Advani AS
Am J Hematol; 2012 Oct; 87(10):957-60. PubMed ID: 22729847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
